Simultaneous Determination of Erlotinib and its Metabolites in Human Urine and Serum Samples by High-Performance Liquid Chromatography-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Simultaneous Determination of Erlotinib and its Metabolites in Human Urine and Serum Samples by High-Performance Liquid Chromatography

Published:2017-02-01 Issue:3 Volume:80 Page:409-415
ISSN:0009-5893
Container-title:Chromatographia
language:en
Short-container-title:Chromatographia

Author:

Rodríguez J.,Castañeda G.,Muñoz L.,Delgado M. C.,Lizcano I.,Villa J. C.,Lopez R.

Funder

Ministerio de Economía y Competitividad

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,Clinical Biochemistry,Biochemistry,Analytical Chemistry

Link

http://link.springer.com/content/pdf/10.1007/s10337-017-3258-6.pdf

Reference21 articles.

1. Grunwald V, Hidalgo M (2002) The epidermal growth factor receptor: a new target for anticancer therapy. Curr Probl Cancer 26:109–164

2. American Society of Clinical Oncology (1997) Clinical practice guidelines for the treatment of unresectable nonsmall-cell lung cancer. J Clin Oncol 15:2996–3018

3. Baselga J, Hammond LA (2002) HER-targeted tyrosinekinase inhibitors. Oncology 63(Suppl 1):6–16

4. Hidalgo M, Siu LL, Nemunaitis J (2001) Phase I and pharmacologic study of OSI-774, an epidermalgrowth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies. J Clin Oncol 19:3267–3279

5. Hidalgo M, Bloedow D (2003) Pharmacokinetics and pharmacodynamics: maximizing the clinical potentialof erlotinib (Tarceva). Semin Oncol 303(Suppl 7):25–33

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology-based Drug Delivery Systems for the Treatment of Cervical Cancer: A Comprehensive Review;Current Nanoscience;2024-03

2. Determination of pKa Values for Some Tyrosine Kinase Inhibitors Using the Reversed-Phase Liquid Chromatography;Journal of Solution Chemistry;2023-03-20

3. Bioanalysis of erlotinib, its O-demethylated metabolites OSI-413 and OSI-420, and other metabolites by liquid chromatography-tandem mass spectrometry with additional ion mobility identification;Journal of Chromatography B;2021-03

4. HPLC methods for quantifying anticancer drugs in human samples: A systematic review;Analytical Biochemistry;2020-12

5. An Exploration of Advancement in Analytical Methodology for Quantification of Anticancer Drugs in Biomatrices;Analytical Sciences;2019-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3